section name header

Evidence summaries

Hormone Replacement Therapy to Maintain Cognitive Function in Women with Dementia

Hormone replacement therapy appears not to be effective in maintaining cognitive function in women with Alzheimer´s disease. Level of evidence: "B"

A Cochrane review [Abstract] 1 included 7 trials involving 351 women with Alzheimer's disease. On a clinical global rating, clinicians scored patients taking CEE as significantly worse compared with the placebo group on the Clinical Dementia Rating scale after 12 months (overall WMD = 0.35, 95% CI 0.01 to 0.69).Patients taking conjugated equine estrogens (CEE) had a worse performance on the delayed recall of the Paragraph Test (overall WMD = -0.45, 95% CI = -0.79 to -0.11) after one month than those taking placebo. They had a worse performance on Finger Tapping after 12 months (WMD = -3.90, 95% CI = -7.85 to 0.05).Limited positive effects were found for the lower dosage of CEE (0.625 mg/day) which showed a significant improvement in MMSE score only when assessed at two months, and disappeared after correction for multiple testing. No significant effects for MMSE were found at longer end points (3, 6 and 12 months of treatment). With a dosage of 1.25 mg/d CEE, short-term significant effects were found for Trial-Making test B at one month and Digit Span backward at four months. After two months of transdermal diestradiol treatment, a highly significant effect was observed for the word recall test (WMD = 6.50, 95% CI = 4.04 to 8.96). No other significant effects were found for other outcomes measured.

Reviewers' conclusions: Currently, HRT or ERT for cognitive improvement or maintenance is not indicated for women with AD. Other types of dementia (e.g. vascular dementia) remain to be investigated.

Comment: The evidence is downgraded by imprecise results (small sample size).

    References

    • Hogervorst E, Yaffe K, Richards M et al. Hormone replacement therapy to maintain cognitive function in women with dementia. Cochrane Database Syst Rev 2009;(1):CD003799. [PubMed]

Primary/Secondary Keywords